Glenmark Life Sciences is quoting at a premium of Rs 90 over its issue price of Rs 720 while Rolex Rings is commanding a GMP of Rs 470 per share
The issue received bids for 4,17,79,260 shares against 1,50,18,279 shares on offer, as per data available with the NSE
The public issue will have a fresh issue of equity shares worth up to Rs 1,060 crore and sale of up to 63 lakh equity shares by Glenmark Pharma
Glenmark Life Sciences has filed a Draft Red Herring Prospectus with SEBI for an initial public offer